News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 887 results

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Glenmark becomes fifth generic to be charged with US antitrust violations

02-07-2020Muireann Bolger

Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

LSPN Connect: MPP chief wants COVID-19 role

26-06-2020Rory O'Neill

The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

English appeals court refuses Neurim injunction for insomnia drug

UK26-06-2020

The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 

Mylan scores multiple sclerosis patent win over Biogen

US23-06-2020

Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court.

UKIPO cancels SPC extension at owner’s request

EU, UK16-06-2020Rory O'Neill

The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

SCOTUS refuses to hear Eli Lilly patent win

US16-06-2020Sarah Morgan

The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.

Unitary SPC should follow new patent system: EC official

11-06-2020Rory O'Neill

The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

US states sue 26 drugmakers over alleged price fixing

US11-06-2020Sarah Morgan

A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

No fees award for PTAB proceedings, rules Fed Circuit

US05-06-2020Rory O'Neill

The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board.

Showing 1 to 10 of 887 results

LSIPR